Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What Does FDA Deem A "Serious Adverse Event"? Matrixx Learns The Hard Way

Executive Summary

A narrower interpretation of "serious adverse event" - compared with FDA's definition - is costing Matrixx Initiatives at least $10 million dollars with the recall of its intranasal Zicam products - assuming FDA cannot be convinced to reverse its position
Advertisement

Related Content

Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers
Commissioner, Chief Counsel See Wiggle Room In FDA's Legal Powers
Firms Have 15 Days To Respond To Inspection Violations Under New FDA Plan
Firms Have 15 Days To Respond To Inspection Violations Under New FDA Plan
FDA says Zicam enforcement routine
FDA says Zicam enforcement routine
Law Could Bring Consumer Products Safety Commission Closer To Cosmetics
2009 FDA Globalization Act Scratches Fees For Cosmetics, “Unanticipated” AEs
House Subcommittee Hearing Explores Alleged Gaps In Cosmetic Safety
House Subcommittee Hearing Explores Alleged Gaps In Cosmetic Safety
Advertisement
UsernamePublicRestriction

Register

RS016253

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel